Drug targets for Plasmodium falciparum:: A post-genomic review/survey

被引:28
作者
Yeh, I [1 ]
Altman, RB [1 ]
机构
[1] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
关键词
malaria; drug targets; plasmodium; metabolism; genomics;
D O I
10.2174/138955706775475957
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Over 300 million cases of malaria each year cause significant morbidity and mortality. Growing drug-resistance among the Plasmodia that cause malaria motivates the development of additional anti-malarial drugs. This review summarizes the current state of knowledge about potential drug targets for malaria. The recently sequenced malaria genome data clarifies parasite metabolic pathways. and more metabolic targets have been identified.
引用
收藏
页码:177 / 202
页数:26
相关论文
共 50 条
  • [21] Inhibition of Protein-protein Interactions in Plasmodium falciparum: Future Drug Targets
    Pierrot, Christine
    Freville, Aline
    Olivier, Christophe
    Souplet, Vianney
    Khalife, Jamal
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (24) : 3522 - 3530
  • [22] Metabolic Pathway and Graph Identification of New Potential Drug Targets for Plasmodium Falciparum
    Tuan Tran
    Ekenna, Chinwe
    2017 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2017, : 1887 - 1893
  • [23] Functional genomic technologies applied to the control of the human malaria parasite, Plasmodium falciparum
    Carucci, DJ
    PHARMACOGENOMICS, 2001, 2 (02) : 137 - 142
  • [24] Drug resistance and genetic mapping in Plasmodium falciparum
    Hayton, Karen
    Su, Xin-zhuan
    CURRENT GENETICS, 2008, 54 (05) : 223 - 239
  • [25] Drug resistance and genetic mapping in Plasmodium falciparum
    Karen Hayton
    Xin-zhuan Su
    Current Genetics, 2008, 54 : 223 - 239
  • [26] Perspectives in the control of infectious diseases by transgenic mosquitoes in the post-genomic era -: A Review
    Speranca, Marcia Aparecida
    Capurro, Margareth Lara
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2007, 102 (04): : 425 - 433
  • [27] Investigative pathology: leading the post-genomic revolution
    Berman, David M.
    Bosenberg, Marcus W.
    Orwant, Robin L.
    Thurberg, Beth L.
    Draetta, Gulio F.
    Fletcher, Christopher D. M.
    Loda, Massimo
    LABORATORY INVESTIGATION, 2012, 92 (01) : 4 - 8
  • [28] Target Discovery and Validation in the Post-Genomic Era
    Steven P. Butcher
    Neurochemical Research, 2003, 28 : 367 - 371
  • [29] Metabolic engineering challenges in the post-genomic era
    Alper, H
    Stephanopoulos, G
    CHEMICAL ENGINEERING SCIENCE, 2004, 59 (22-23) : 5009 - 5017
  • [30] The hepatic stellate cell in the post-genomic era
    Okuyama, H
    Shimahara, Y
    Kawada, N
    HISTOLOGY AND HISTOPATHOLOGY, 2002, 17 (02) : 487 - 495